Inventor · disambiguated record
Dirk Gretzke
Also filed as: GRETZKE DIRK
15 granted patents·5 pending applications·130 citations·filing 2004–2025
90Inventor score
Files withSANOFI AVENTIS DEUTSCHLAND9SANOFI SA6AVENTIS PHARMA GMBH3BOHME THOMAS1SANOFI AVENTISDEUTSCHAND GMBH1
Top patents by PatentIndex Score
20 records- 0196US7223788B2Substituted N-aryl heterocycles, process for their preparation and their use as medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted May 29, 2007·81 cites·14 claims
- 0288US11827633B2Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2021·Granted Nov 28, 2023·1 cites·17 claims
- 0386US7148246B2Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Dec 12, 2006·18 cites·13 claims
- 0484US12275733B2Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2023·Granted Apr 15, 2025·0 cites·9 claims
- 0579US11130755B2Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2017·Granted Sep 28, 2021·2 cites·12 claims
- 0679US7335671B2Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Feb 26, 2008·9 cites·9 claims
- 0779US7160911B2Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jan 9, 2007·14 cites·12 claims
- 0874US7968550B2Substituted N-aryl heterocycles, process for their preparation and their use as medicamentsAVENTIS PHARMA GMBH·Filed 2007·Granted Jun 28, 2011·1 cites·19 claims
- 0973US2025333412A1Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2025·Application pending·0 cites
- 1070US7259177B2Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Aug 21, 2007·3 cites·10 claims
- 1165US7872034B2Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Granted Jan 18, 2011·0 cites·9 claims
- 1263US2008015238A1Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 1359US2024360194A1New Peptides as Potent and Selective GIP Receptor AgonistsSANOFI SA·Filed 2022·Application pending·0 cites
- 1458US7365084B2Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Apr 29, 2008·0 cites·17 claims
- 1556US8048901B21,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticalsAVENTIS PHARMA GMBH·Filed 2007·Granted Nov 1, 2011·0 cites·26 claims
- 1652US2004209932A11,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticalsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 1751US2023103631A1Peptides as selective gip receptor agonistsSANOFI SA·Filed 2021·Application pending·0 cites
- 1848US7173151B2Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTISDEUTSCHAND GMBH·Filed 2004·Granted Feb 6, 2007·1 cites·14 claims
- 1947US7220876B2Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted May 22, 2007·0 cites·15 claims
- 2044US8076324B2Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising themBOHME THOMAS·Filed 2009·Granted Dec 13, 2011·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →